These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 12028325

  • 1. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan.
    Géraud G, Spierings EL, Keywood C.
    Headache; 2002 Apr; 42 Suppl 2():S93-9. PubMed ID: 12028325
    [Abstract] [Full Text] [Related]

  • 2. Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: Results of a new analysis of data from five previously published studies.
    MacGregor EA, Pawsey SP, Campbell JC, Hu X.
    Gend Med; 2010 Apr; 7(2):88-108. PubMed ID: 20435272
    [Abstract] [Full Text] [Related]

  • 3. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 4. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA, Brandes JL, Silberstein S, Jeka S, Czapinski P, Shaw B, Pawsey S.
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [Abstract] [Full Text] [Related]

  • 5. Frovatriptan: a review of its use in the acute treatment of migraine.
    Sanford M.
    CNS Drugs; 2012 Sep 01; 26(9):791-811. PubMed ID: 22900951
    [Abstract] [Full Text] [Related]

  • 6. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J, Keywood C, 251/96/14 Study Group.
    Headache; 2002 Jan 01; 42(1):41-8. PubMed ID: 12005274
    [Abstract] [Full Text] [Related]

  • 7. Frovatriptan review.
    Markus F, Mikko K.
    Expert Opin Pharmacother; 2007 Dec 01; 8(17):3029-33. PubMed ID: 18001261
    [Abstract] [Full Text] [Related]

  • 8. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine.
    Balbisi EA.
    Int J Clin Pract; 2004 Jul 01; 58(7):695-705. PubMed ID: 15311727
    [Abstract] [Full Text] [Related]

  • 9. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW.
    Headache; 2001 May 01; 41(5):449-55. PubMed ID: 11380642
    [Abstract] [Full Text] [Related]

  • 10. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct 01; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

  • 11. Spotlight on almotriptan in migraine.
    Keam SJ, Goa KL, Figgitt DP.
    CNS Drugs; 2002 Oct 01; 16(7):501-7. PubMed ID: 12056924
    [Abstract] [Full Text] [Related]

  • 12. Almotriptan: a review of its use in migraine.
    Keam SJ, Goa KL, Figgitt DP.
    Drugs; 2002 Oct 01; 62(2):387-414. PubMed ID: 11817980
    [Abstract] [Full Text] [Related]

  • 13. Frovatriptan.
    Easthope SE, Goa KL.
    CNS Drugs; 2001 Oct 01; 15(12):969-76; discussion 977-8. PubMed ID: 11735616
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
    Silberstein SD, Elkind AH, Schreiber C, Keywood C.
    Neurology; 2004 Jul 27; 63(2):261-9. PubMed ID: 15277618
    [Abstract] [Full Text] [Related]

  • 15. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May 27; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

  • 16. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.
    Ferrari MD, Goadsby PJ, Roon KI, Lipton RB.
    Cephalalgia; 2002 Oct 27; 22(8):633-58. PubMed ID: 12383060
    [Abstract] [Full Text] [Related]

  • 17. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.
    Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH.
    Neurology; 2000 Jan 11; 54(1):156-63. PubMed ID: 10636142
    [Abstract] [Full Text] [Related]

  • 18. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul 11; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M, Hee A, Emeribe U, Silberstein S.
    CNS Drugs; 2006 Jul 11; 20(12):1019-26. PubMed ID: 17140280
    [Abstract] [Full Text] [Related]

  • 20. Frovatriptan: pharmacological differences and clinical results.
    Rapoport AM.
    Curr Med Res Opin; 2001 Jul 11; 17 Suppl 1():s68-70. PubMed ID: 12463282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.